Diabetes, Digestive, and Kidney Diseases Extramural Research in New Jersey
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $53.7 million to recipients in New Jersey in 52 grants from fiscal 2021 to 2025, 0.6% of the program's national total. Rutgers the State University of New Jersey received the most, $31.6 million.
- Awarded in New Jersey$53.7 million
- Awards52
- Share of the program0.6%
- Rank among states30th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 20 | $5.7 million |
| FY 2022 | 24 | $8.8 million |
| FY 2023 | 29 | $11.4 million |
| FY 2024 | 33 | $13.6 million |
| FY 2025 | 34 | $14.2 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rutgers the State University of New Jersey | Colleges and universities | 26 | $31.6 million |
| Rutgers, the State University | Colleges and universities | 12 | $16.8 million |
| Rutgers, the State University | Colleges and universities | 3 | $2.2 million |
| The Trustees of Princeton University | Colleges and universities | 4 | $1.4 million |
| Rutgers, the State University | Colleges and universities | 3 | $860,323 |
| Myracle Therapeutics Inc | Small businesses | 1 | $324,466 |
| United Biotherapeutics LLC | Small businesses | 1 | $307,508 |
| Lactiga Us Inc. | Small businesses | 1 | $303,427 |
| Rutgers, the State University | Colleges and universities | 1 | $11,535 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to New Jersey?
$53.7 million from fiscal 2021 to 2025, across 52 awards. New Jersey ranks 30th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in New Jersey?
The largest recipient is Rutgers the State University of New Jersey, with $31.6 million in 26 awards. Next are Rutgers, the State University and Rutgers, the State University.
Can organizations in New Jersey apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies